CN
CN

Webinars

Insights from target to IND

Learn More

Chem-on-Demand

Bridging Synthesis to Your Success

Learn More

Latest Sciences

Recent posters and published articles

Learn More
WuXi AppTec Discovery Services

Delivering our partners preclinical discoveries through world class capabilities,

directed by teams with a reputation for collaboration and scientific excellence

Learn More
Latest Science
Webinars
Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

Webinars

Insights from target to IND

Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

Magical Power of QM
With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

Magical Power of QM

To Empower Organic Syntheses

With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

Bifunctional Molecules
Bifuctional molecules are opening up once-inaccessible targets and enabling development of drugs that are less susceptible to target protein mutations.

Bifunctional Molecules

A Diverse New Modality That Unlocks New Target Classes

Bifuctional molecules are opening up once-inaccessible targets and enabling development of drugs that are less susceptible to target protein mutations.

CRISPR Library Screen
Cancer is a genetic disease. Over time, somatic mutations accumulate and drive the proliferation of tumor cells. Knowledge of that process has spurred systematic efforts to identify genes essential to the survival of different cancer cells.

CRISPR Library Screen

A Powerful Tool For Identifying Novel Tumor Targets

Cancer is a genetic disease. Over time, somatic mutations accumulate and drive the proliferation of tumor cells. Knowledge of that process has spurred systematic efforts to identify genes essential to the survival of different cancer cells.

Science
Identification and characterization of new bifunctional molecules including degraders using synergistic power of fragment and DEL screening, biophysics and structural biology

Science

Enabling Technology for Targeted Protein Degradation

Identification and characterization of new bifunctional molecules including degraders using synergistic power of fragment and DEL screening, biophysics and structural biology

Rare Disease
The word “rare” in the term rare disease can be confusing to the uninitiated. About 300 million people worldwide are living with one or more of over 6,000 rare diseases. This is just under 4% of the world population. So it’s not actually rare to have a rare disease.

Rare Disease

Opportunities and Challenges for Treatments Delivered by Adeno-Associated Viruses

The word “rare” in the term rare disease can be confusing to the uninitiated. About 300 million people worldwide are living with one or more of over 6,000 rare diseases. This is just under 4% of the world population. So it’s not actually rare to have a rare disease.

Upcoming Events

New Technologies for Target Discovery and Validation

February 16, 2022

Texas Life Science Forum

February 24, 2022

ESMO Targeted Anticancer Therapies Congress 2022

March 7-8, 2022

OPT Congress

March 15-16, 2022

8th Fragment-based Drug Discovery Meeting

March 27-29, 2022

AACR Annual Meeting 2022

April 8-13, 2022

Drug Discovery Chemistry 2022

April 18-22, 2022

NLSDays 2022

April 20-21, 2022